Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
Bayesian End-Member Mixing Model
1. Bayesian end-member mixing analysis with explicit
consideration of unobserved end-members
and measurement uncertainty
Andreas Scheidegger
Andrea Popp
Christian Möck
Matthias Brennwald
EGU − April 10th, 2019
11. Conclusions
Measurement errors:
Observation model
Structural model
limitations:
Residual end-
member as error source
• Protects from over-confidence
• Combines expert knowledge
• Allows to learn from model errors
• Can guide future experiments
Making assumption explicit:
Source of all pictograms: thenounproject.com Thanks!Andreas Scheidegger